ID   HEC-88nu
AC   CVCL_2932
SY   HEC-88 nu; HEC88nu; HEC88NU; HEC-88
DR   BioSample; SAMN03470941
DR   Cosmic; 1223493
DR   Cosmic; 1696751
DR   IARC_TP53; 21069
DR   JCRB; JCRB1121
DR   JCRB; NIHS0393
DR   Wikidata; Q54882269
RX   DOI=10.1007/978-4-431-53981-0_1;
RX   DOI=10.5795/jjscc.26.433;
RX   PubMed=2064198;
RX   PubMed=12227503;
RX   PubMed=15053063;
RX   PubMed=25877200;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Characteristics: Established from a tumor transplanted in nude mice.
CC   Doubling time: 43.8 hours (Note=At 58th passage) (DOI=10.5795/jjscc.26.433); 48 hours (PubMed=2064198).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Discontinued: JCRB; NIHS0393; true.
ST   Source(s): JCRB=JCRB1121; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 8,13
ST   D16S539: 11
ST   D18S51: 14,16,17
ST   D19S433: 13
ST   D21S11: 29,31.2
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,16
ST   FGA: 21,22
ST   Penta D: 9,12
ST   Penta E: 5,15
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu, Ma-Mie
RA   Selvaraj, Suresh K.
RA   Liang-Chu, May M.Y.
RA   Aghajani, Sahar
RA   Busse, Matthew
RA   Yuan, Jean
RA   Lee, Genee
RA   Peale, Franklin V.
RA   Klijn, Christiaan
RA   Bourgon, Richard
RA   Kaminker, Joshua S.
RA   Neve, Richard M.
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//
RX   PubMed=15053063;
RA   Kamata, Yuko
RA   Watanabe, Junichi
RA   Hata, Hiroki
RA   Hamano, Mieko
RA   Kuramoto, Hiroyuki
RT   "Quantitative study on the correlation between p53 gene mutation and
RT   its expression in endometrial carcinoma cell lines.";
RL   Eur. J. Gynaecol. Oncol. 25:55-60(2004).
//
RX   PubMed=12227503; DOI=10.1111/j.1749-0774.2002.tb00103.x;
RA   Kuramoto, Hiroyuki
RA   Hamano, Mieko
RA   Imai, Manami
RT   "HEC-1 cells.";
RL   Hum. Cell 15:81-95(2002).
//
RX   PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076;
RA   Li, Jun
RA   Zhao, Wei
RA   Akbani, Rehan
RA   Liu, Wen-Bin
RA   Ju, Zhen-Lin
RA   Ling, Shi-Yun
RA   Vellano, Christopher P.
RA   Roebuck, Paul
RA   Yu, Qing-Hua
RA   Eterovic, Agda Karina
RA   Byers, Lauren Averett
RA   Davies, Michael A.
RA   Deng, Wan-Leng
RA   Gopal, Y.N. Vashisht
RA   Chen, Guo
RA   von Euw, Erika Maria
RA   Slamon, Dennis Joseph
RA   Conklin, Dylan
RA   Heymach, John Victor
RA   Gazdar, Adi F.
RA   Minna, John D.
RA   Myers, Jeffrey N.
RA   Lu, Yi-Ling
RA   Mills, Gordon B.
RA   Liang, Han
RT   "Characterization of human cancer cell lines by reverse-phase protein
RT   arrays.";
RL   Cancer Cell 31:225-239(2017).
//
RX   DOI=10.5795/jjscc.26.433;
RA   Morisawa, Takayuki
RT   "The results of primary culture of endometrial adenocarcinoma and
RT   characterization of its established cell line.";
RL   Nihon Rinsho Saibo Gakkai Zasshi 26:433-442(1987).
//
RX   DOI=10.1007/978-4-431-53981-0_1;
RA   Kuramoto, Hiroyuki
RA   Hamano, Mieko
RA   Imai, Manami
RA   Fujisawa, Takesi
RA   Kamata, Yuko
RA   Arai, Tsutomu
RA   Kawaguchi, Miwa
RT   "HEC-1 cells: establishment of an in vitro experimental system in
RT   endometrial carcinoma.";
RL   (In book chapter) Cell and molecular biology of endometrial carcinoma; Kuramoto, Hiroyuki & Nishida, Masato (eds.); pp.3-34; Springer; Tokyo; Japan (2003).
//
RX   PubMed=2064198; DOI=10.1111/j.1749-6632.1991.tb37884.x;
RA   Kuramoto, Hiroyuki
RA   Nishida, Masato
RA   Morisawa, Takayuki
RA   Hamano, Mieko
RA   Hata, Hiroki
RA   Kato, Yoshiki
RA   Ohno, Eiji
RA   Iida, Tomohiro
RT   "Establishment and characterization of human endometrial cancer cell
RT   lines.";
RL   Ann. N. Y. Acad. Sci. 622:402-421(1991).
//